2. We suggest that screening for malignancy prior to transplantation be conducted in accordance with usual age and sex appropriate cancer screening policies for the general population. (Ungraded) [Comment: This could be a recommendation if it is felt to be an obvious clinical decision i.e. there would be no reason not to do it from a risk/benefit even though it is ungraded.] 3. We suggest that consideration be given to the following minimum waiting periods from successful treatment of malignancy to transplantation. Nil
To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.